BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 81 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $9,818,000 | +42.7% | 176,258 | +17.0% | 0.00% | +100.0% |
| Q3 2016 | $6,882,000 | +23.3% | 150,695 | +7.8% | 0.00% | 0.0% |
| Q2 2016 | $5,582,000 | +25.4% | 139,760 | +9.3% | 0.00% | 0.0% |
| Q1 2016 | $4,451,000 | -22.3% | 127,825 | -4.1% | 0.00% | 0.0% |
| Q4 2015 | $5,726,000 | +2.9% | 133,250 | +4.2% | 0.00% | 0.0% |
| Q3 2015 | $5,567,000 | -16.2% | 127,861 | -0.7% | 0.00% | -50.0% |
| Q2 2015 | $6,644,000 | +61.3% | 128,769 | +22.4% | 0.00% | +100.0% |
| Q1 2015 | $4,120,000 | +2.9% | 105,238 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $4,004,000 | +24.9% | 103,682 | +14.1% | 0.00% | 0.0% |
| Q3 2014 | $3,207,000 | +22.3% | 90,845 | -6.6% | 0.00% | 0.0% |
| Q2 2014 | $2,623,000 | +500.2% | 97,274 | +477.3% | 0.00% | – |
| Q1 2014 | $437,000 | +21.7% | 16,851 | +1.7% | 0.00% | – |
| Q4 2013 | $359,000 | +16.2% | 16,577 | +4.3% | 0.00% | – |
| Q3 2013 | $309,000 | +35.5% | 15,887 | +8.5% | 0.00% | – |
| Q2 2013 | $228,000 | – | 14,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 211,370 | $9,833,000 | 5.80% |
| JW Asset Management, LLC | 73,649 | $3,426,000 | 2.51% |
| NORTHPOINTE CAPITAL LLC | 135,657 | $6,311,000 | 0.67% |
| Elk Creek Partners, LLC | 170,102 | $7,913,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 156,167 | $7,265,000 | 0.32% |
| Ativo Capital Management LLC | 22,592 | $1,051,000 | 0.28% |
| Matarin Capital Management, LLC | 59,077 | $2,748,262,000 | 0.23% |
| ISTHMUS PARTNERS, LLC | 16,753 | $779,000 | 0.22% |
| CADENCE CAPITAL MANAGEMENT LLC | 29,586 | $1,376,000 | 0.09% |
| ALGERT GLOBAL LLC | 7,834 | $364,000 | 0.08% |